Nicole Doria-Rose

Doria-Rose graduated from Hunter College High School in New York City in 1987. She obtained her Bachelor of Arts in biology in 1991 and a Ph.D. in 1998 from Cornell University. During her doctoral studies, she trained under advisor Volker Vogt in the department of biochemistry, molecular and cell biology.^[2] Her dissertation was titled In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal.^[1]

From 1998 to 2003, Doria-Rose worked as a postdoctoral scientist in the laboratory of Nancy Haigwood at the Seattle Biomedical Research Institute (SBRI) and the department of pathobiology at University of Washington. Doria-Rose was promoted to the position of associate scientist at SBRI in 2003. While working as a post-doctoral fellow, Doria-Rose was also appointed as associate faculty in the science department at Shoreline Community College in 2000.^[2]

Doria-Rose joined the National Institute of Allergy and Infectious Diseases in 2006 as a senior research fellow in the laboratory of immunoregulation. In 2011, she became a staff scientist at the Vaccine Research Center, where she has worked on isolating new, potent anti-HIV monoclonal antibodies and studying their development over time. In 2012, she was promoted to the position of Chief of the humoral immunology core.^[2]

Doria-Rose develops and applies assays to evaluate HIV-1 specific antibody responses during natural infection and after immunization.^[2]